How to reduce nephropathy following contrast-enhanced CT: A lesson in policy implementation

Clinical Radiology

Volumn 67, Issue 12, 2012, Pages 1136-1145

  Richenberg, J ^a  

^a Worthing Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BICARBONATE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IODINATED CONTRAST MEDIUM; SODIUM CHLORIDE;

ANGIOCARDIOGRAPHY; ANGIOGRAPHY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; CONTRAST ENHANCEMENT; CONTRAST INDUCED NEPHROPATHY; COST BENEFIT ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG WITHDRAWAL; EXTRACELLULAR SPACE; HEALTH CARE COST; HEART CATHETERIZATION; HUMAN; HYDRATION; KIDNEY FAILURE; KIDNEY FUNCTION; LACTIC ACIDOSIS; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; RISK ASSESSMENT; RISK REDUCTION; TERTIARY HEALTH CARE; URINARY EXCRETION;

CLINICAL PROTOCOLS; CONTRAST MEDIA; GREAT BRITAIN; HUMANS; KIDNEY DISEASES; ORGANIZATIONAL POLICY; RISK ASSESSMENT; RISK FACTORS; TERTIARY CARE CENTERS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84869082827     PISSN: 00099260     EISSN: 1365229X     Source Type: Journal    
DOI: 10.1016/j.crad.2012.05.003     Document Type: Review

References (130)

1. W.F. Finn The clinical and renal consequences of contrast-induced nephropathy Nephrol Dial Transplant 21 2006 i2 10
2. C. Briguori, D. Tavano, and A. Colombo Contrast agent-associated nephrotoxicity Prog Cardiovasc Dis 45 2003 493 503
3. K. Nash, A. Hafeez, and S. Hou Hospital-acquired renal insufficiency Am J Kidney Dis 39 2002 930 936
4. H.S. Thomsen Current evidence on prevention and management of contrast-induced nephropathy Eur Radiol 17 Suppl. 6 2007 F33 F37
5. T.G. Gleeson, and S. Bulugahapitiya Contrast-induced nephropathy AJR Am J Roentgenol 183 2004 1673 1689
6. R. Mehran, and E. Nikolsky Contrast-induced nephropathy: definition, epidemiology, and patients at risk Kidney Int 69 Suppl. S100 2006 S11 S15
7. R. Solomon, and B. Barrett Follow-up of patients with contrast-induced nephropathy Kidney Int 69 Suppl. S100 2006 S46 S50
8. R.J. Solomon, R. Mehran, and M.K. Natarajan Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol 4 2009 1162 1169
9. M.R. Rudnick, S. Goldfarb, and L. Wexler Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study Kidney Int 47 1995 254 261
10. G. Sterner, U. Nyman, and T. Valdes Low risk of contrast-medium-induced nephropathy with modern angiographic technique J Intern Med 250 2001 429 434
11. J.R. Brown, D.J. Malenka, and J.T. DeVries Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention: insights from the Dartmouth Dynamic Registry Catheter Cardiovasc Interv 72 2008 347 354
12. A.M. From, B.J. Bartholmai, and A.W. Williams Mortality associated with nephropathy after radiographic contrast exposure Mayo Clin Proc 83 2008 1095 1100
13. S.E. Miner, V. Dzavik, and P. Nguyen-Ho N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up Am Heart J 148 2004 690 695
14. M. Rudnick, and H. Feldman Contrast-induced nephropathy: what are the true clinical consequences? Clin J Am Soc Nephrol 3 2008 263 272
15. B.J. Barrett, and P.S. Parfrey Clinical practice. Preventing nephropathy induced by contrast medium N Engl J Med 354 2006 379 386
16. H. Reinecke, M. Fobker, and J. Wellmann A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus- Diuresis (DVD) Trial Clin Res Cardiol 96 2007 130 139
17. S.H. Hou, D.A. Bushinsky, and J.B. Wish Hospital-acquired renal insufficiency: a prospective study Am J Med 74 1983 243 248
18. P.A. McCullough, M.E. Bertrand, and J.A. Brinker A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media J Am Coll Cardiol 48 2006 692 699
19. B.R. Herts, E. Schneider, and E.D. Poggio Identifying outpatients with renal insufficiency before contrast-enhanced CT by using estimated glomerular filtration rates versus serum creatinine levels Radiology 248 2008 106 113
20. R. Lencioni, R. Fattori, and G. Morana Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT) - a clinical problem in daily practice? A multicenter observational study Acta Radiol 51 2010 741 750
21. S.M. Kim, R.H. Cha, and J.P. Lee Incidence and outcomes of contrast-induced nephropathy after computed tomography in patients with CKD: a quality improvement report Am J Kidney Dis 55 2010 1018 1025
22. A.S. Levey, J.P. Bosch, and J.B. Lewis A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470
23. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
24. J.B. Ashley, and S.F. Millward Contrast agent-induced nephropathy: a simple way to identify patients with preexisting renal insufficiency AJR Am J Roentgenol 181 2003 451 454
25. M.A. Bettmann Contrast medium-induced nephropathy: critical review of the existing clinical evidence Nephrol Dial Transplant 20 Suppl. 1 2005 i12 i17
26. O. Toprak What is the best definition of contrast-induced nephropathy? Ren Fail 29 2007 387 388
27. P.M. Palevsky Defining contrast-induced nephropathy Clin J Am Soc Nephrol 4 2009 1151 1153
28. S. Subramanian, J. Tumlin, and B. Bapat Economic burden of contrast-induced nephropathy: implications for prevention strategies J Med Econ 10 2007 119 134
29. A.M. Mitchell, A.E. Jones, and J.A. Tumlin Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting Clin J Am Soc Nephrol 5 2010 4 9
30. J.H. Ellis, and R.H. Cohan Reducing the risk of contrast-induced nephropathy: a perspective on the controversies AJR Am J Roentgenol 192 2009 1544 1549
31. Q.A. Rao, and J.H. Newhouse Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis Radiology 239 2006 392 397
32. J.H. Newhouse, D. Kho, and Q.A. Rao Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity AJR Am J Roentgenol 191 2008 376 382
33. D.A. Baumgarten, and J.H. Ellis Contrast-induced nephropathy: contrast material not required? AJR Am J Roentgenol 191 2008 383 386
34. P.A. McCullough, F. Stacul, and C.R. Becker Contrast-Induced Nephropathy (CIN) Consensus Working Panel: executive summary Rev Cardiovasc Med 7 2006 177 197
35. R.W. Katzberg, and B.J. Barrett Risk of iodinated contrast material-induced nephropathy with intravenous administration Radiology 243 2007 622 628
36. R.W. Katzberg, and R. Lamba Contrast-induced nephropathy after intravenous administration: fact or fiction? Radiol Clin North Am 47 2009 789 800
37. M. El-Hajjar, I. Bashir, and M. Khan Incidence of contrast-induced nephropathy in patients with chronic renal insufficiency undergoing multidetector computed tomographic angiography treated with preventive measures Am J Cardiol 102 2008 353 356
38. P. Calabro, R. Bianchi, and M. Caprile Use of NaCl saline hydration and N-acetyl cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography Minerva Cardioangiol 58 2010 35 40
39. P. Calabro, R. Bianchi, and M. Crisci Use and efficacy of saline hydration and N-acetyl cysteine to prevent contrast-induced nephropathy in low-risk populations undergoing coronary artery angiography Intern Emerg Med 6 2011 503 507
40. S. Detrenis, M. Meschi, and M. del Mar Jordana Sanchez Contrast medium induced nephropathy in urological practice J Urol 178 2007 1164 1170
41. V.E. Friedewald, S. Goldfarb, and W.K. Laskey The Editor's roundtable: contrast agents and risk for contrast-induced nephropathy Am J Cardiol 107 2011 1848 1855
42. S.K. Goergen, G. Rumbold, and G. Compton Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin Radiology 254 2010 261 269
43. M. Kanbay, A. Covic, and S.G. Coca Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials Int Urol Nephrol 41 2009 617 627
44. M.J. Kuhn, N. Chen, and D.V. Sahani The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure AJR Am J Roentgenol 191 2008 151 157
45. L. Lepanto, A. Tang, and J. Murphy-Lavallee The Canadian Association of Radiologists guidelines for the prevention of contrast-induced nephropathy: a critical appraisal Can Assoc Radiol J 62 2011 238 242
46. R. Liu, D. Nair, and J. Ix N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis J Gen Intern Med 20 2005 193 200
47. A. Maliborski, P. Zukowski, and G. Nowicki Contrast-induced nephropathy - a review of current literature and guidelines Med Sci Monit 17 2011 RA199 RA204
48. P.A. McCullough, A. Adam, and C.R. Becker Risk prediction of contrast-induced nephropathy Am J Cardiol 98 2006 27K 36K
49. P.A. McCullough, A. Adam, and C.R. Becker Epidemiology and prognostic implications of contrast-induced nephropathy Am J Cardiol 98 2006 5K 13K
50. M. Meschi, S. Detrenis, and S. Musini Facts and fallacies concerning the prevention of contrast medium-induced nephropathy Crit Care Med 34 2006 2060 2068
51. S. Nawaz, T. Cleveland, and P.A. Gaines Clinical risk associated with contrast angiography in metformin treated patients: a clinical review Clin Radiol 53 1998 342 344
52. N. Pannu, N. Wiebe, and M. Tonelli Prophylaxis strategies for contrast-induced nephropathy JAMA 295 2006 2765 2779
53. R. Solomon, and G. Deray How to prevent contrast-induced nephropathy and manage risk patients: practical recommendations Kidney Int 69 (Suppl. S100 2006 S51 S53
54. F. Stacul, A. Adam, and C.R. Becker Strategies to reduce the risk of contrast-induced nephropathy Am J Cardiol 98 2006 59K 77K
55. F. Stacul, A.J. van der Molen, and P. Reimer Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines Eur Radiol 21 2011 2527 2541
56. D.A. Stenstrom, L.L. Muldoon, and H. Armijo-Medina N-acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials J Vasc Interv Radiol 19 2008 309 318
57. H.S. Thomsen, and S.K. Morcos Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent diabetics after administration of contrast media. ESUR Contrast Media Safety Committee Eur Radiol 9 1999 738 740
58. H.S. Thomsen, and S.K. Morcos In which patients should serum creatinine be measured before iodinated contrast medium administration? Eur Radiol 15 2005 749 754
59. H.S. Thomsen, and S.K. Morcos Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines Eur Radiol 16 2006 1835 1840
60. H.S. Thomsen, S.K. Morcos, and B.J. Barrett Contrast-induced nephropathy: the wheel has turned 360 degrees Acta Radiol 49 2008 646 657
61. O. Toprak Risk markers for contrast-induced nephropathy Am J Med Sci 334 2007 283 290
62. O. Toprak Is acquired immunodeficiency syndrome a risk for development of contrast-induced nephropathy? Can Assoc Radiol J 59 2008 100
63. J.T. Van Praet, and A.S. De Vriese Prevention of contrast-induced nephropathy: a critical review Curr Opin Nephrol Hypertens 16 2007 336 347
64. (2006) Proceeding of the Contrast-Induced Nephropathy Consensus Panel, 17 September 2005, Paris, France. Kidney Int 69(Suppl. S100):S1-53.
65. D. Reddan, M. Laville, and V.D. Garovic Contrast-induced nephropathy and its prevention: what do we really know from evidence-based findings? J Nephrol 22 2009 333 351
66. ACR manual on contrast media 2005, The Committee on Drugs and Contrast Media of the American College of Radiology American College of radiology 1981 Preston White drive, Reston, VA 20191-4378 USA.
67. O. Toprak, and M. Cirit Risk factors for contrast-induced nephropathy Kidney Blood Press Res 29 2006 84 93
68. N.H. Lameire Contrast-induced nephropathy - prevention and risk reduction Nephrol Dial Transplant 21 2006 i11 i23
69. T. Feldkamp, and A. Kribben Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention Minerva Med 99 2008 177 196
70. J.H. Ellis, and R.H. Cohan Prevention of contrast-induced nephropathy: an overview Radiol Clin North Am 47 2009 801 811
71. H.S. Trivedi, H. Moore, and S. Nasr A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity Nephron Clin Pract 93 2003 C29 C34
72. B. Dussol, S. Morange, and A. Loundoun A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients Nephrol Dial Transplant 21 2006 2120 2126
73. A.J. Taylor, D. Hotchkiss, and R.W. Morse PREPARED: Preparation for Angiography in Renal Dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction Chest 114 1998 1570 1574
74. B.D. Bader, E.D. Berger, and M.B. Heede What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? Clin Nephrol 62 2004 1 7
75. R.A. Krasuski, B.M. Beard, and J.D. Geoghagan Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study J Invasive Cardiol 15 2003 699 702
76. S.D. Weisbord, K.C. Hartwig, and A.F. Sonel The incidence of clinically significant contrast-induced nephropathy following non-emergent coronary angiography Catheter Cardiovasc Interv 71 2008 879 885
77. S.D. Weisbord, M.K. Mor, and A.L. Resnick Incidence and outcomes of contrast-induced AKI following computed tomography Clin J Am Soc Nephrol 3 2008 1274 1281
78. R. Cho, N. Javed, and D. Traub Oral hydration and alkalinization is noninferior to intravenous therapy for prevention of contrast-induced nephropathy in patients with chronic kidney disease J Interv Cardiol 23 2010 460 466
79. E. Nikolsky, and R. Mehran Hydration protocols to reduce the incidence of contrast-induced nephropathy J Invasive Cardiol 20 2008 527 538
80. S.D. Navaneethan, S. Singh, and S. Appasamy Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis Am J Kidney Dis 53 2009 617 627
81. K.M. Ho, and D.J. Morgan Use of isotonic sodium bicarbonate to prevent radiocontrast nephropathy in patients with mild pre-existing renal impairment: a meta-analysis Anaesth Intensive Care 36 2008 646 653
82. S.E. Hogan, P. L'Allier, and S. Chetcuti Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis Am Heart J 156 2008 414 421
83. H. Trivedi, R. Nadella, and A. Szabo Hydration with sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of randomized controlled trials Clin Nephrol 74 2010 288 296
84. V. Kunadian, A. Zaman, and I. Spyridopoulos Sodium bicarbonate for the prevention of contrast induced nephropathy: a meta-analysis of published clinical trials Eur J Radiol 79 2011 48 55
85. S. Zoungas, T. Ninomiya, and R. Huxley Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy Ann Intern Med 151 2009 631 638
86. M.R. Rudnick, and S. Goldfarb Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality Rev Cardiovasc Med 4 Suppl. 5 2003 S28 S33
87. P. Meier, D.T. Ko, and A. Tamura Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis BMC Med 7 2009 23
88. A. Tamura, Y. Goto, and K. Miyamoto Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure Am J Cardiol 104 2009 921 925
89. R. Barreto Prevention of contrast-induced nephropathy: the rational use of sodium bicarbonate Nephrol Nurs J 34 2007 417 421
90. A. Benko, M. Fraser-Hill, and P. Magner Canadian Association of Radiologists: consensus guidelines for the prevention of contrast-induced nephropathy Can Assoc Radiol J 58 2007 79 87
91. R.E. Cronin Contrast-induced nephropathy: pathogenesis and prevention Pediatr Nephrol 25 2010 191 204
92. E.K. Fishman, and D. Reddan What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography Acta Radiol 49 2008 310 320
93. A.M. Kelly, B. Dwamena, and P. Cronin Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy Ann Intern Med 148 2008 284 294
94. M. Meschi, S. Detrenis, and G. Savazzi [Contrast-induced nephropathy. Current concepts and propositions for Italian guidelines] Recenti Prog Med 99 2008 155 162
95. P.C. Wong, Z. Li, and J. Guo Pathophysiology of contrast-induced nephropathy Int J Cardiol 2011 Jul 22, [Epub ahead of print]
96. M. Tepel, M. van der Giet, and C. Schwarzfeld Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine N Engl J Med 343 2000 180 184
97. E. Alamartine, M. Phayphet, and D. Thibaudin Contrast medium-induced acute renal failure and cholesterol embolism after radiological procedures: incidence, risk factors, and compliance with recommendations Eur J Intern Med 14 2003 426 431
98. C.A. Naughton Drug-induced nephrotoxicity Am Fam Physician 78 2008 743 750
99. N. Pannu, and M.K. Nadim An overview of drug-induced acute kidney injury Crit Care Med 36 Suppl. 2008 S216 S223
100. D. Reddan, and E.K. Fishman Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists Eur J Radiol 66 2008 235 245
101. S.K. Morcos Contrast-induced nephropathy: are there differences between low osmolar and iso-osmolar iodinated contrast media? Clin Radiol 64 2009 468 472
102. E. Seeliger, K. Becker, and M. Ladwig Up to 50-fold increase in urine viscosity with iso-osmolar contrast media in the rat Radiology 256 2010 406 414
103. P.B. Persson Contrast-induced nephropathy Eur Radiol 15 Suppl. 4 2005 D65 D69
104. G. Jost, H. Pietsch, and J. Sommer Retention of iodine and expression of biomarkers for renal damage in the kidney after application of iodinated contrast media in rats Invest Radiol 44 2009 114 123
105. P. Liss, P.B. Persson, and P. Hansell Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media Kidney Int 70 2006 1811 1817
106. H. Trivedi, and W.D. Foley Contrast-induced nephropathy after a second contrast exposure Ren Fail 32 2010 796 801 10.3109/0886022X.2010.495441
107. W. Adair, K. Harris, and J. Entwisle Using estimated GFR values to identify patients at risk from iodinated contrast induced nephropathy Clin Radiol 61 8 2006 714 715 10.1016/j.crad.2006.03.013
108. C. Eken, and I. Kilicaslan Differences between various glomerular filtration rate calculation methods in predicting patients at risk for contrast-induced nephropathy Am J Emerg Med 25 4 2007 487 10.1016/j.ajem.2007. 03.023
109. O. Toprak Conflicting and new risk factors for contrast induced nephropathy J Urol 178 2007 2277 2283
110. O. Toprak, and M. Cirit Risk factors and therapy strategies for contrast-induced nephropathy Ren Fail 28 5 2003 365 381 10.1080/ 08860220600683524
111. R. Solomon Contrast-induced nephropathy: update with special emphasis on patients with diabetes Curr Diab Rep 7 6 2007 454 458
112. P.S. Parfrey, S.M. Griffiths, and B.J. Barrett Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study N Engl J Med 320 3 1989 143 149 10.1056/NEJM198901193200303
113. J.K. Pahade, C.A. LeBedis, and V.D. Raptopoulos Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT AJR Am J Roentgenol 196 5 2011 1094 1101 10.2214/AJR.10.5152
114. G. Westberg Withdraw metformin prior to contrast radiography. A warning in the Fass was forgotten, two patients died Lakartidningen 92 24 1995 2520
115. G.D. Pond, S.H. Smyth, D.J. Roach, and G. Hunter Metformin and contrast media: genuine risk or witch hunt? Radiology 201 3 1996 879 880
116. M.J. Duddy Metformin and contrast: the risk Clin Radiol 53 4 1998 310
117. D.I. Hammond, and P. Rasuli Metformin and contrast media Clin Radiol 53 12 1998 933 934
118. P. Rasuli, G.J. French, and D.I. Hammond Metformin hydrochloride all right before, but not after, contrast medium administration Radiology 209 2 1998 586 587
119. P. Rasuli, and D.I. Hammond Metformin and contrast media: where is the conflict? Can Assoc Radiol J 49 3 1998 161 166
120. M.M. McCartney, F.J. Gilbert, L.E. Murchison, D. Pearson, K. McHardy, and A.D. Murray Metformin and contrast media-a dangerous combination? Clin Radiol 54 1 1999 29 33
121. S. Landewe-Cleuren, W.H. van Zwam, T.W. de Bruin, and M. de Haan Prevention of lactic acidosis due to metformin intoxication in contrast media nephropathy Ned Tijdschr Geneeskd 144 40 2000 1903 1905
122. Metformin and intravascular contrast media National guidelines 2001-03-16 Lakartidningen 98 16 2001 1935 1936
123. N.E. Klow, B. Draganov, and I. Os Metformin and contrast media-increased risk of lactic acidosis? Tidsskr Nor Laegeforen 121 15 2001 1829
124. R. Gupta Use of intravenous contrast agents in patients receiving metformin Radiology 225 1 2002 311 312 author reply 312
125. R. Gupta Should intravenous contrast be used in patients receiving metformin Am J Emerg Med 20 4 2002 374
126. D. Parra, A.M. Legreid, N.P. Beckey, and S. Reyes Metformin monitoring and change in serum creatinine levels in patients undergoing radiologic procedures involving administration of intravenous contrast media Pharmacotherapy 24 8 2004 987 993
127. N.H. Bjarnason, and T. Elung-Jensen Nephrotoxicity after the use of intravenous X-ray contrast media in a type 2 diabetic being treated with metformin Ugeskr Laeger 168 18 2006 1772 1773
128. J.A. Sayer Acute renal failure from contrast medium: beware patients taking metformin BMJ 333 7569 2006 653 10.1136/bmj.333.7569.653-a
129. V. Jain, D. Sharma, H. Prabhakar, and H.H. Dash Metformin-associated lactic acidosis following contrast media-induced nephrotoxicity Eur J Anaesthesiol 25 2 2008 166 167
130. H.S. Thomsen, S.K. Morcos, and T. Almen Metformin and contrast media Radiology 256 2 2010 672 673 10.1148/radiol.100566 author reply 673